NOVEL COMBINATION OF NON-SEDATING ANTIHISTAMINES WITH SUBSTANCES WHICH INFLUENCE LEUKOTRIENE ACTION, FOR THE TREATMENT OF RHINITIS /CONJUNCTIVITIS

摘要

A pharmaceutical combination for the topical or oral administration of a nonsedating antihistamine with the exception of compounds of the loratadine type in combination with a leukotriene antagonist selected from a leukotriene D4 antagonist or 5-lipoxygenase inhibitor or FLAP antagonist and, if appropriate, customary physiologically acceptable vehicles, extenders and excipients for the prophylaxis and treatment of allergic and/or vasomotor rhinitis or allergic conjunctivitis is described.